Inixaciclib, CAS [[2370913-42-9]]

Product Overview

• Article Name: Inixaciclib, CAS [[2370913-42-9]]
• Biozol Catalog Number: MCE-HY-45661
• Supplier Catalog Number: HY-45661
• Alternative Catalog Number: MCE-HY-45661-100MG,MCE-HY-45661-50MG,MCE-HY-45661-10MG,MCE-HY-45661-25MG,MCE-HY-45661-5MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: NUV-422

Product Description

Inixaciclib (NUV-422) is a blood-brain barrier-penetrant inhibitor of CDK2, CDK4 and CDK6. Inixaciclib inhibits cancer cell growth. Inixaciclib induces anti-tumor activity in xenograft models of glioblastoma, CDK4/CDK6 inhibitor-resistant HR+ HER2- metastatic breast cancer, and anti-androgen-resistant prostate cancer. Inixaciclib can be used for the research of relapsed or metastatic castration-resistant prostate cancer[1].

Product Properties

• Molecular Weight: 480.55
• Purity: 99.93
• CAS Number: [2370913-42-9]
• Formula: C26H30F2N6O
• Target: CDK

Application Notes

• Application Notes: MCE Product type: Reference compound